CLINICAL_TRIALS
trial_result
· 2010-02-03
Clinical Trial Update: Safety Study of Olopatadine Nasal Spray [Phase 3]
Summary
Phase 3 safety study of olopatadine nasal spray for perennial allergic rhinitis has completed, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2010-02-03